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Otitis media (OM) is a group of complex inflammatory disorders affecting the middle
ear which can be acute or chronic. Chronic suppurative otitis media (CSOM) is a
form of chronic OM characterized by tympanic membrane perforation and discharge.
Despite the significant impact of CSOM on human population, it is still an understudied
and unexplored research area. CSOM is a leading cause of hearing loss and
life-threatening central nervous system complications. Bacterial exposure especially
Pseudomonas aeruginosa is the most common cause of CSOM. Our previous studies
have demonstrated that P. aeruginosa invades human middle ear epithelial cells
(HMEECs). However, molecular mechanisms leading to bacterial invasion of HMEECs
are not known. The aim of this study is to characterize the role of PKC pathway in
the ability of P. aeruginosa to colonize HMEECs. We observed that otopathogenic
P. aeruginosa activates the PKC pathway, specifically phosphorylation of PKC-alpha
(PKC-α) in HMEECs. The ability of otopathogenic P. aeruginosa to phosphorylate PKC-
α depends on bacterial OprF expression. The activation of PKC-α was associated
with actin condensation. Blocking the PKC pathway attenuated the ability of bacteria
to invade HMEECs and subsequent actin condensation. This study, for the first time,
demonstrates that the host PKC-α pathway is involved in invasion of HMEECs by
P. aeruginosa and subsequently to cause OM. Characterizing the role of the host
signaling pathway in the pathogenesis of CSOM will provide novel avenues to design
effective treatment modalities against the disease.
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INTRODUCTION
Otitis media (OM) refers to inflammation of the middle ear and mastoid cavity which can be acute
or chronic (Minovi and Dazert, 2014; Qureishi et al., 2014). OM accounts for more than 25 million
visits to physician’s offices annually and is associated with significant healthcare costs (Klein, 2000;
Monasta et al., 2012). The global burden of disease study has attributed 4.68 million disability-
adjusted life years (DALYs) to OM, a disease burden that is almost as high as the intestinal helminth
infections (Murray et al., 2012). OM recurrence rates are high and acute OM (AOM) can progress
to chronic OM (COM) despite appropriate treatment (Morris and Leach, 2009). One form of COM
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is chronic suppurative otitis media (CSOM) characterized
by tympanic membrane perforation and purulent discharge
(Verhoeff et al., 2006; Li MG et al., 2015). Children are at
greater risk and suffer most frequently from CSOM, causing
serious deterioration in their quality of life (Olatoke et al.,
2008; Aarhus et al., 2015). CSOM remains an important global
public health problem leading to hearing impairment, which
may have serious long term effects on language, auditory, and
cognitive development, as well as the educational progress of
children (Elemraid et al., 2010; Taipale et al., 2011; Kolo et al.,
2012; Jensen et al., 2013; Mittal et al., 2015). In addition,
due to the proximity of ear to the brain, the spread of
suppuration to the central nervous system (CNS) can lead to
fatal extracranial and intracranial complications (Seven et al.,
2005; Hossain et al., 2006; Dubey et al., 2010; Sun and Sun,
2014). Approximately 28,000 deaths are reported per year
from CSOM due to CNS complications including brain abscess
and meningitis (Acuin, 2004). Beside advances in medical
therapy, CSOM still remains a clinically challenging disease.
Despite the significant impact of CSOM on human population,
the molecular mechanisms underlying the disease are still
unknown. The emergence of antibiotic resistance and potential
ototoxicity of antibiotics has created an immediate incentive to
develop effective treatment modalities against CSOM. To design
these therapeutic strategies, there is a need to understand the
pathogenesis of CSOM. Bacterial infection of the middle ear is
the most important factor that predisposes individuals to CSOM
(Bluestone, 1998). Pseudomonas aeruginosa is the most common
pathogen associated with CSOM (Saini et al., 2005; Yeo et al.,
2007; Dayasena et al., 2011; Madana et al., 2011; Afolabi et al.,
2012; Sattar et al., 2012). Our previous studies have demonstrated
that P. aeruginosa invades human middle ear epithelial cells
(HMEECs) and induces cytoskeletal rearrangements (Mittal
et al., 2014). However, molecular mechanisms leading to actin
condensation and invasion of HMEECs by P. aeruginosa are not
known.
Protein kinase C (PKC) is a central host molecule that has
been implicated in cytoskeletal reorganization (Brandt et al.,
2002). A number of actin-binding proteins regulate the structure
and dynamics of the actin cytoskeleton through organization
of F-actin into a three-dimensional structure (dos Remedios
et al., 2003; Paavilainen et al., 2004). Activities of these actin-
binding proteins are controlled through various host signaling
pathways to ensure proper spatial and temporal regulation of
actin dynamics in cells (Khurana and George, 2008). One such
signal transduction pathway that affects the actin cytoskeleton is
the PKC pathway (Long and Freeley, 2014). PKC regulates the
morphology of the F-actin cytoskeleton and thereby influences
processes that are affected by remodeling of the microfilaments
including cellular migration and neurite growth (Larsson, 2006;
Quann et al., 2011; Michalczyk et al., 2013). PKC is composed
of a family of phospholipid-dependent serine/threonine kinases
mediating diverse cellular responses (Newton, 1995). In general,
PKC has a catalytic domain that contains the ATP binding
site and a regulatory domain containing the phospholipid and
diacylglycerol (DAG) binding site (Luo and Weinstein, 1993; Poli
et al., 2014).
Since PKC plays a central role in signaling events leading to
changes in the cell membrane and cytoskeleton (Brandt et al.,
2002), we hypothesized that PKC activation plays a crucial
role in the invasion of HMEECs by P. aeruginosa. Our results
showed that the PKC pathway is indeed involved in the ability of
P. aeruginosa to colonize HMEECs and cause actin condensation.
PKC inhibitors significantly blocked the invasion of HMEECs by
otopathogenic P. aeruginosa. We also observed that P. aeruginosa
of ear origin activates PKC during invasion of HMEECs for
which bacterial OprF expression is necessary. The activated PKC
translocates to the plasma membrane to initiate downstream
signaling transduction events. To the best of our knowledge, this
study for the first time demonstrates the role of PKC pathway in
the pathogenesis of CSOM.
MATERIALS AND METHODS
Cell Culture
Human middle ear epithelial cells (kindly provided by Dr.
David Lim) were generated from human middle ear mucosa as
described earlier (Mittal et al., 2014; Woo et al., 2015). HMEECs
were cultured and maintained as described earlier (Lim and
Moon, 2011; Mittal et al., 2014; Woo et al., 2014, 2015; Val
et al., 2015). Briefly, HMEECs were cultured in a 1:1 mixture
of Bronchial Epithelial Cell Basal Medium (Lonza, Allendale,
NJ, USA) and Dulbecco’s Modified Eagle Medium (Cellgro,
Manassas, VA, USA) supplemented with bronchial epithelial
growth medium (BEGM) Singlequots (Lonza, Allendale, NJ,
USA) and 10% fetal bovine serum (Life Technologies, Carlsbad,
CA, USA). In some experiments, HMEECs were transfected with
DN-PKC-α (Addgene Cambridge, MA, USA; Soh and Weinstein,
2003) using TransIT R©-LT1 transfection reagent (Mirus, Madison,
WI, USA) as per the manufacturer’s instructions. In separate
experiments, HMEECs were treated with different concentrations
of PKC inhibitors or actin polymerization or microtubule
disrupting agents and then subjected to invasion assay.
Bacterial Strains
A clinical otopathogenic strain of P. aeruginosa isolated from
CSOM patient attending University of Miami Hospital is used
in this study. The strain was identified and characterized as
described previously (MacFaddin, 1976; Forbes et al., 1998; Saini
et al., 2005; Yeo et al., 2007; Dayasena et al., 2011; Madana et al.,
2011; Afolabi et al., 2012; Sattar et al., 2012). The isogenic OprF
mutant (1oprF) and respective plasmid complemented strain
(pOprF) consisting of the functional oprF gene was generated as
described earlier (Woodruff and Hancock, 1989; Horton et al.,
1990; Rietsch et al., 2005; Fito-Boncompte et al., 2011; Yakhnina
et al., 2015). Bacteria were grown overnight in Luria broth at 37◦C
in a rotary shaker.
Invasion Assays
Gentamicin protection assays were used to quantify the extent
of bacterial invasion of HMEECs (Mittal et al., 2014). Briefly,
HMEECs were infected with bacteria at various multiplicity of
infection (MOI) and for different time-periods. After incubation,
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the cells were washed five times with warm RPMI followed
by addition of medium containing gentamicin (200 µg/ml)
and further incubated for 1 h at 37◦C. The cells were washed
three times with RPMI and then lysed with 1% saponin to
release intracellular bacteria. Serial dilutions were then plated
on blood agar plates and bacterial colonies were counted the
next day. The binding of bacteria to HMEECs was determined
by lysing the cells without adding gentamicin. To determine the
effect of PKC inhibitors, HMEECs were pretreated with different
concentrations of PKC inhibitory or control peptide, BIM I, Gö-
6976, calphostin C, and chelerythrine for 30 min before infecting
with bacteria and maintained in the medium for the entire
infection period.
PepTag Assay for Non-radioactive
Detection of PKC Activity
The activation of PKC in HMEECs in response to P. aeruginosa
infection was assessed by PepTag assay as per the manufacturer’s
instructions (Promega, Madison, WI, USA). The assay uses
brightly colored, fluorescent peptide substrates that are highly
specific for the kinases in question. The hot pink color is
imparted by the addition of a dye molecule to the PepTag Peptide
substrate. Phosphorylation of PKC alters the peptide’s net charge
from +1 to –1. This change in the net charge of the substrate
allows the phosphorylated and non-phosphorylated versions of
the substrate to be rapidly separated on an agarose gel. The
phosphorylated species migrates toward the positive electrode,
while the non-phosphorylated substrate migrates toward the
negative electrode. HMEECs total cell lysates or membrane
fractions (10–25 µg in 10 µl) were incubated with PKC reaction
mixture at 33◦C for 30 min. The reactions were stopped by
placing the tubes in a boiling water bath. Samples were then
run on agarose gel and bands were visualized under UV
light.
Quantitation of Extent of
Phosphorylation by Spectrophotometry
Spectrophotometric method was used to quantitate PKC kinase
activity as per manufacturer’s instructions. The phosphorylated
bands at the negative electrode were excised by scalpel blade
immediately after imaging the gel followed by heating at 95◦C.
The volume of the solution was adjusted to 250 µl with water.
Samples were then mixed with gel solubilization buffer and glacial
acetic acid followed by transferring to 96 well plates and reading




Cells were infected with bacteria for different post-infection
time periods, and lysates prepared. Protein concentrations of the
extracts were measured using a BCA assay (Pierce, Rockford,
IL, USA). Equivalent amounts of extracts were subjected to
SDS-PAGE, transferred onto nitrocellulose membranes, and then
blotted as described previously (Mittal and Prasadarao, 2010).
For quantification, the Densitometric analysis was done using
ImageJ software. For immunoprecipitation, cell lysates were
incubated with anti-actin antibody overnight at 4◦C followed by
addition of Protein A+G sepharose beads. Immunoprecipitated
beads were washed, resuspended in SDS sample buffer and
resolved on SDS-PAGE. Immunoprecipitated proteins were
transferred to nitrocellulose membrane and analyzed by Western
blotting with anti- phospho-PKC-α antibody.
Preparation of Membrane and Cytosolic
Fractions
The membrane and cytosolic fractions were prepared from
HMEECs using commercially available kit (Biovision, Milpitas,
CA, USA) as per the manufacturer’s instructions.
Immunofluorescence Microscopy
For staining of bacteria and actin, HMEECs were cultured
in 8-well chamber slides and infected with P. aeruginosa for
varying time periods. After incubation, cells were washed
three times with PBS buffer and then fixed and permeabilized
with BD cytofix and cytoperm reagent (BD Biosciences, San
Jose, CA, USA) for 30 min. After washing, the cells were
blocked with 3% normal goat serum (NGS) for 30 min and
then incubated with anti-Phospho PKC-α antibody (Abcam,
Cambridge, MA, USA) for 45 min followed by Alexa Fluor 488
antibody (Life Technologies, Carlsbad, CA, USA). After washing,
cells were counterstained for actin with rhodamine phalloidin
(Life Technologies, Carlsbad, CA, USA) for 45 min, washed
and mounted in an antifade Vectashield solution containing
4′,6-diamidino-2-phenylindole (DAPI; Vector Laboratories,
Burlingame, CA, USA). The cells were viewed with a Zeiss
LSM 710 microscope (Carl Zeiss, Germany) and images were
assembled using Adobe Photoshop 7.0.
Statistical Analysis
Statistical significance was determined by a paired, two-tailed
Student’s t-test using SPSS software. Values of P < 0.05 were
considered to be statistically significant.
RESULTS
PKC Inhibitors Attenuate Invasion of
HMEECs by P. aeruginosa
Our previous studies have demonstrated that P. aeruginosa can
invade HMEECs and induce cytopathic effects (Mittal et al.,
2014). To determine the role of PKC in cell invasion, HMEECs
were infected with P. aeruginosa in the presence and absence of
different concentrations of PKC inhibitors, bisindolylmaleimide
I (BIM I), Gö-6976, PKC inhibitory peptide, calphostin C and
chelerythrine. Bacterial cell invasion was then determined by
gentamicin protection assay. We observed that with increase
in concentrations of PKC inhibitors, there was significant
decrease in invasion of HMEECs by P. aeruginosa (P < 0.01;
Figures 1A–C). A concentration of 10 µM of BIM I was able to
inhibit the invasion of P. aeruginosa by 50% whereas a dose of
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FIGURE 1 | PKC inhibitors prevent invasion of HMEECs by P. aeruginosa. HMEECs were pretreated with different concentrations of BIM I (A), Gö-6976 (B),
PKC inhibitory peptide (C), or control peptide (D) for 30 min and then infected with P. aeruginosa at an MOI of 10 for 2 h. Bacterial adhesion and invasion was then
determined. The results are expressed as percentage compared to the bacterial adhesion/invasion in untreated infected cells. Data represents mean ± SD and is
representative of four individual experiments carried out in triplicate. ∗P < 0.01 or ∗∗P < 0.001 compared to control.
30 µM was able to inhibit invasion by 90% (Figure 1A). Gö-
6976 was able to block the invasion of P. aeruginosa by 85%
at a concentration of 15 µM (Figure 1B). The myristoylated
PKC inhibitory peptide at a concentration of 50 µM was able
to block the invasion by 40% whereas a dose of 90 µM was
able to inhibit the cell invasion by 80% (Figure 1C). However,
control peptide had no effect on the invasion of P. aeruginosa
into HMEECs at any of the tested concentrations (Figure 1D).
Similar results of decreased cell invasion was observed with other
PKC inhibitors, calphostin C and chelerythrine (Supplementary
Figures S1 and S2). We did not observe any difference in the
binding of P. aeruginosa to HMEECs in the presence of PKC
inhibitors (Figures 1A–C and Supplementary Figures S1 and S2)
indicating that the observed differences in invasion were not due
to the differential bacterial binding. We also did not observe
any toxic effects of these reagents on bacteria or on cells at the
tested concentrations (data not shown). These results suggest
that PKC plays a crucial role in colonization of HMEECs by
P. aeruginosa.
P. aeruginosa Activates PKC during
HMEECs Invasion for Which OprF
Expression is Required
Since we observed that PKC plays a role in cell invasion,
next we determined whether P. aeruginosa activates PKC in
HMEECs. Our previous studies have demonstrated that bacterial
OprF expression is required for the invasion of HMEECs by
P. aeruginosa (Mittal et al., 2014). Therefore, we examined the
ability of wild-type (WT) and 1oprF mutant of P. aeruginosa to
activate PKC in HMEECs by PepTag assay. Cells were infected
with otopathogenic P. aeruginosa for varying time periods and
PKC activation was determined using non-radioactive PepTag
assay. HMEECs infected with WT P. aeruginosa demonstrated
PKC activation within 30 min, which peaked at 90 min and
then decreased at 120 min post-infection (Figure 2A). The
increased PKC activity was approximately fourfold compared
with PKC activity in control uninfected cells as estimated by
the spectrophotometric method using phosphorylated substrate
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FIGURE 2 | Otopathogenic P. aeruginosa requires OprF to activate PKC in HMEECs. Cells were infected with different strains of P. aeruginosa for varying
time periods and subjected to non-radioactive PepTag assay (A). PKC activity was quantified by excising the phosphorylated bands from the agarose gel and results
were expressed in kinase units/ml (B). In separate experiments, P. aeruginosa was pretreated with anti-OprF monoclonal antibody (mAb) or mouse IgG or left
untreated and then used in the PKC assay (C,D). Data represents mean ± SD. Results are representative of five independent experiments. #P > 0.05 or ∗P < 0.001.
peptides (Figure 2B). In contrast, 1oprF mutant induced
significantly lower PKC activation than WT P. aeruginosa
(∗P < 0.01). However, the cells infected with the complemented
strain (pOprF strain) showed a similar pattern of PKC activation
as the WT strain. These results suggest that interaction of OprF
with HMEECs activates downstream signaling leading to cell
invasion by P. aeruginosa.
To determine whether OprF has direct influence on the
ability of P. aeruginosa to activate PKC, bacteria were pretreated
with anti-OprF monoclonal antibody (mAb) and then used to
infect HMEECs. Bacteria pretreated with isotype antibody or
left untreated and uninfected served as the control group. We
observed that anti-OprF monoclonal antibody treated bacteria
failed to elicit PKC activation in HMEECs (Figures 2C,D). These
results suggest that OprF directly contributes to the activation of
PKC in HMEECs in response to P. aeruginosa infection.
EGTA Treatment Abrogates P. aeruginosa
Induced PKC Activation
Calcium plays an important role in the activation and regulation
of conventional PKC isoforms which are most commonly
implicated in cytoskeletal rearrangements (Herbert et al., 1990;
Farah and Sossin, 2012). Therefore, we treated HMEECs with
ethylene glycol tetraacetic acid (EGTA) to chelate calcium and
infected with P. aeruginosa. Total cell lysates were then prepared
and subjected to PepTag assay. We observed that PKC activation
was completely abolished following pretreatment with EGTA
(Figure 3A). Quantification of this data confirmed that EGTA
significantly abrogated P. aeruginosa induced PKC activation in
HMEECs compared to untreated cells (∗P < 0.001; Figure 3B).
These findings suggest that the PKC activated in HMEECs
following P. aeruginosa can be the conventional PKC isoform,
PKC-α.
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FIGURE 3 | EGTA abolishes P. aeruginosa induced PKC activation in
HMEECs. Cells were pretreated with EGTA for 30 min, and infected with
P. aeruginosa. Total cell lysates were prepared and subjected to PepTag assay
(A). Quantitation of PKC activity by spectrophotometric assay demonstrated
that EGTA prevents P. aeruginosa induced PKC activation in HMEECs (B).
Results are representative of three independent experiments. ∗P < 0.001.
Otopathogenic P. aeruginosa Specifically
Activates PKC-α in HMEECs
Next we set forth to determine the PKC isotype activated by
P. aeruginosa in HMEECs. PKC family is comprised of different
isoforms that trigger distinct host signal transduction pathways
(Newton, 1995). Cells were infected with WT, 1oprF mutant
or pOprF strains of P. aeruginosa for varying time-period,
total cell lysates prepared and subjected to Western blotting.
We observed that P. aeruginosa activated only PKC-α but not
the other isoforms namely, PKC-γ and PKC-δ (Figure 4A).
Time course study using anti-phospho-PKC-α specific antibodies
revealed that P. aeruginosa phosphorylates PKC-α within 30 min
post-infection, showing a peak at 90 min post-infection, and
then decreases gradually afterward (Figure 4B). However,
1oprF mutant failed to show any phosphorylation of PKC-α
(Figure 4A). The ability of 1oprF mutant to phosphorylate PKC
was regained following complementation with pOprF. This data
confirms our earlier PepTag assay data that phosphorylation
of PKC-α in response to P. aeruginosa requires bacterial OprF
expression.
Pseudomonas aeruginosa Induces
Translocation of PKC to the Membrane
The migration of phosphorylated PKC to the plasma membrane
is essential in order to initiate downstream signaling (Newton,
1995). Therefore, we examined whether phosphorylated PKC
in response to P. aeruginosa infection translocate to the
FIGURE 4 | P. aeruginosa specifically activates PKC in HMEECs. Cells
were infected with P. aeruginosa for 30, 60, 90, and 120 min post-infection.
Total cell lysates were prepared and subjected to Western blotting using either
anti-phospho-PKC-α, anti-phospho-PKC-γ, or anti-phospho-PKC-δ
antibodies (A). The blots were stripped and reprobed with respective PKC
antibodies to confirm equal loading of proteins (A). The intensity of bands
normalized to total PKC-α from two different blots was then calculated for
quantification of phosphorylation of PKC-α (B). Results are representative of
three independent experiments. ∗P < 0.001.
plasma membrane of HMEECs. HMEECs were infected with
P. aeruginosa and membrane fractions were prepared using
commercially available kit (Biovision, Milpitas, CA, USA).
PepTag assay revealed that phosphorylated PKC resides in the
membrane (Figure 5A). We observed the same pattern of PKC
activation in membrane fractions as we observed in total cell
lysates. There was a fourfold increase in PKC activity at 90 min
post-infection as compared to that at 30 min post-infection
followed by a gradual decline in PKC activity at 120 min post-
infection (Figure 5B).
To further confirm these results, we subjected the membrane
fractions to Western blotting. We observed that in agreement
with our PepTag assay, phosphorylated PKC-α was located in
the membrane fraction (Figure 5C). There was an increase in
phosphorylation of PKC-αwith a corresponding increase in post-
infection time period from 30 to 90 min as indicated by increase
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FIGURE 5 | Activated PKC localizes in the plasma membrane. To determine the localization of activated PKC, membrane fractions were prepared from
P. aeruginosa infected HMEECs and subjected to PepTag assay (A). Quantitation of data showed that activated PKC resides in the membrane fraction (B). In
separate experiments, membrane fractions prepared from P. aeruginosa infected HMEECs were subjected to Western blotting and probed with anti-phospho-PKC-α
antibody (C). The blots were stripped and reprobed with anti-alpha 1 sodium potassium ATPase antibody (plasma membrane marker) to confirm equal loading of
proteins. The intensity of bands normalized to plasma membrane marker was then calculated for quantification from two different blots (D). Results are
representative of three independent experiments. ∗P < 0.001.
in band intensity followed by a gradual decline at 120 min post-
infection (Figure 5D). Taken together, these results suggest that
P. aeruginosa induced activated PKC translocate to the plasma
membrane.
Overexpression of Dominant Negative
Form of PKC-α Inhibits PKC Activation
and Invasion of HMEECs by
P. aeruginosa
To characterize the role of PKC-α in cell invasion by
P. aeruginosa, HMEECs were transfected with dominant negative
(DN) PKC-α plasmid or vector alone or left untransfected.
The DN PKC-α expression plasmid (PKC-α-cat/KR) encodes a
truncated protein in which the N-terminal regulatory domain
is deleted, while the catalytic domain (cat) containing amino
acids 326–672 of PKC is preserved with a point mutation that
abolishes the ATP binding ability (Soh and Weinstein, 2003).
To determine whether expression of DN-PKC-α will prevent the
activation of P. aeruginosa induced PKC, HMEECs lysates were
subjected to PepTag assay. We observed that PKC activation was
significantly attenuated in DN-PKC-α transfected cells compared
to vector control or untransfected cells (Figure 6A). DN-PKC-
α transfected cells showed fivefold decrease in PKC activation
compared to vector control or untransfected cells (P < 0.001;
Figure 6A). Similar results of decreased expression of PKC-α in
DN-PKC-α transfected cells were observed with Western blotting
(Figures 6B,C). In agreement with this data, the expression of
DN-PKC-α into HMEECs significantly prevented the invasion of
P. aeruginosa into HMEECs (Figure 6D). However, we did not
observe any significant decrease in adhesion of P. aeruginosa to
HMEECs (Figure 6D). This data demonstrates that colonization
of HMEECs by P. aeruginosa requires active PKC-α.
Phospho PKC-α Associates with Actin in
P. aeruginosa Infected HMEECs
In our previous studies, we observed that P. aeruginosa induces
actin condensation during cell invasion (Mittal et al., 2014).
Since PKC can play a central role in cytoskeletal rearrangements,
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FIGURE 6 | Overexpression of dominant-negative (DN) PKC-α abolishes PKC activation and P. aeruginosa invasion. HMEECs were transfected with DN
PKC-α or vector alone or left untransfected, infected with P. aeruginosa and then subjected to PepTag assay. PKC kinase activity was then determined in DN PKC-α
transfected cells or vector alone or untransfected HMEECs (A). In separate experiments, total cell lysates from P. aeruginosa infected DN PKC-α or vector alone or
left untransfected were subjected to Western blotting (B). The extent of PKC-α phosphorylation was determined by densitometric analysis normalized to PKC-α from
two different blots (C). The invasion and adhesion of P. aeruginosa was also determined (D). Results are representative of four independent experiments carried out
in triplicate. ∗P < 0.001.
we determined whether phospho-PKC-α colocalizes with actin
bundles in P. aeruginosa infected HMEECs. Cells were infected
with P. aeruginosa and stained with phospho-PKC-α antibody
followed by secondary staining with Alexa Fluor 488. Cells
were counterstained with rhodamine phalloidin to stain actin.
Uninfected cells showed long actin filaments and no phospho-
PKC-α staining (Figures 7Aa–d). In contrast, P. aeruginosa
infected cells demonstrated actin accumulation beneath the
bacterial binding sites that co-localizes with phospho-PKC-α
staining at majority of sites as indicated by yellow color
(Figures 7Ae–h). However, HMEECs infected with 1oprF
mutant failed to show actin condensation and phospho-PKC-α
staining (Figures 7Ai–l). The overexpression of DN-PKC-α also
prevented actin condensation and phosphorylation of PKC in
agreement with our earlier data (Figures 7Am–p).
To confirm whether phospho-PKC-α associates with actin, we
immunoprecipitated actin and then probed for phospho-PKC-
α in P. aeruginosa infected HMEEC lysates. On par with our
confocal microscopy results, we observed that phosphorylated
PKC-α associates with actin in P. aeruginosa infected HMEECs
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FIGURE 7 | Activated PKC colocalizes with the actin condensation.
HMEECs were left uninfected (Aa–d) or infected with WT (Ae–h) or 1oprF
mutant (Ai–l) P. aeruginosa and then stained with phospho-PKC-α antibody
followed by Alex Fluor 488. Cells were counterstained with
rhodamine-phalloidin to stain actin, DAPI to stain cell nuclei and subjected to
confocal microscopy. In some experiments, HMEECs were transfected with
DN-PKC-α (Am–p), infected with WT P. aeruginosa and then subjected to
confocal microscopy. In separate experiments, actin immunoprecipitates
prepared from HMEECs were separated by SDS-PAGE and blotted with
anti-phospho-PKC-α antibody (B). Results are representative of three
independent experiments.
(Figure 7B). However, no such association between actin
and phospho-PKC-α was observed in 1oprF mutant infected
HMEECs or cells overexpressing DN-PKC-α. These results
suggest that activated PKC-α in P. aeruginosa infected HMEECs
interacts with actin cytoskeleton.
Infection of HMEECs with P. aeruginosa
Promotes Translocation of MARCKs
from Plasma Membrane to Cell Cytosol
The myristoylated alanine-rich C kinase substrate (MARCKS)
is one of the prominent substrates of PKC (Arbuzova et al.,
2002). MARCKS normally resides in the plasma membrane
where it plays a crucial role in the regulation of actin cytoskeleton
(Arbuzova et al., 2002). Upon activation by PKC, MARCKs
migrates from plasma membrane to the cytosol. Therefore we
examined whether MARCKS translocate from plasma membrane
to cytosol in HMEECs in response to P. aeruginosa infection.
HMEECs were infected with P. aeruginosa, cytosolic and
membrane fractions prepared and subjected to Western blotting.
We observed that there was a decrease in MARCKs band
intensity with increase in time period from 30 to 120 min
post-infection in the membrane fraction of HMEECs infected
with WT P. aeruginosa (Figure 8A). Quantification of this data
confirmed that there was a 3.5-fold decrease in the presence
of MARCKs in the membrane fraction at 120 min post-
infection compared to at 30 min post-infection. On the other
hand, MARCKS band intensity increased with increase in post-
infection time period in the cytosolic fraction (Figure 8A).
Densitometric analysis revealed a fivefold increase in MARCKs
expression in the cytosol at 120 min post-infection compared
to at 30 min post-infection. On the contrary, 1oprF mutant
showed no increase in the MARCKs expression in the cytosol or
its decrease in the membrane fraction (Figures 8A,B). This data
suggest that OprF expression on P. aeruginosa is involved in the
translocation of MARCKs from membrane to cytosol. However,
the expression of DN-PKC-α prevented the translocation of
MARCKs from membrane to cytosol in WT P. aeruginosa
infected cells suggesting that activation of PKC is necessary for
this translocation (Figures 8A,B).
DISCUSSION
Chronic suppurative otitis media is the most prevalent disease
worldwide, especially in developing countries, associated with
potentially serious long term sequelae including hearing loss
and fatal brain diseases. CSOM refers to insidious and chronic
intractable inflammation of mucosa as well as submucosa with
destruction of bone of the middle ear cleft characterized by
persistent perforation of the tympanic membrane and recurrent
otorrhea. The presence of bacteria in the middle ear and mastoid
cavity is the most common cause of CSOM. However, the
molecular mechanisms underlying CSOM are not known.
The invasion of bacteria into the host cells is considered
a prerequisite to cause infection. Our previous studies have
demonstrated that P. aeruginosa invades HMEECs in a dose and
time dependent manner. However, molecular mechanisms that
leads to colonization of HMEECs are not known. In this study, we
demonstrated that PKC plays a central role in HMEECs invasion
by P. aeruginosa. PKC specific inhibitors such as BIM I, Gö-
6976, PKC inhibitory peptide, calphostin C and chelerythrine
were able to block the bacterial cell invasion by more than
70–80%. BIM I is a cell permeable, very potent, specific, and
selective inhibitor of PKC (Wanger et al., 2015). Gö-6976 is
another PKC inhibitor that prevents the activation of calcium
dependent isoforms in nanomolar concentrations while having
no effect on the kinase activity of the calcium-independent PKC
subtypes even at micromolar doses (Wang et al., 2015). PKC
inhibitory peptide resembles the pseudosubstrate sequence of
PKC-α whose function is to keep these kinases in their inactive
state; thus, this peptide is a very specific competitive inhibitor of
PKC-α (Eichholtz et al., 1993). Myristoylation of PKC inhibitory
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FIGURE 8 | P. aeruginosa promotes translocation of PKC substrate,
MARCKs, from membrane to cytosol in HMEECs. Cells were left
uninfected or infected with WT or OprF P. aeruginosa strains for varying
time-periods, membrane and cytosolic fractions prepared and subjected to
Western blotting with anti-MARCKs antibody (A). In some experiments,
HMEECs were transfected with DN-PKC-α before infecting with bacteria. The
intensity of the bands was calculated by densitometric analysis and ratio of
membrane associated to cytosolic MARCKs was calculated (B). Results are
representative of three independent experiments.
peptide makes it cell permeable and facilitates the entry inside
cells. Calphostin C is a perylenequinone metabolite that targets
classical and novel PKC isoforms and inhibits both phorbol ester
binding and phosphotransferase activity of PKC through binding
to the regulatory domain (Kobayashi et al., 1989; Xiao et al.,
2015). Chelerythrine is a benzophenanthridine that is a potent
and selective antagonist of classical as well as novel PKCs that
targets the catalytic domain (Li SJ et al., 2015). Our results are
in agreement with the findings of previous studies that showed
that PKC inhibitors can prevent cell invasion by pathogenic
microbes. The entry of a number of pathogenic viruses into host
cells including the vesicular stomatitis virus, herpes simplex I
virus, turkey herpes virus, vaccinia virus, Sindbis virus, human
herpesvirus 8, and adenovirus type 2 has been shown to be
blocked by PKC inhibitors (Constantinescu et al., 1991; Naranatt
et al., 2003; Sieczkarski et al., 2003). BIM-I inhibits the entry of
influenza virus inside Mink lung epithelial cells (Mv-1) during
early infectious stages without affecting the viral binding as
observed in the present study (Root et al., 2000). Earlier studies
have also demonstrated that Cryptosporidium species utilizes
PKC pathway to invade primary human and bovine intestinal
cells (Hashim et al., 2006). PKC inhibitors significantly prevented
the cell invasion by Cryptosporidium species. In agreement with
our invasion data, we observed that P. aeruginosa activates PKC
in HMEECs as early as 30 min post-infection, showing peak
activation at 90 min post-infection. However, to the best of
our knowledge, this study for the first time demonstrated the
PKC activation for the invasion of HMEECs by otopathogenic
bacteria.
PKCs are involved in a large variety of cell functions and signal
transduction pathways regulating cell migration and polarity,
proliferation, differentiation, and cell death (Newton, 1995).
At least twelve different isoforms of PKC have been reported
which have been categorized into three main types based on
calcium dependency and activators: classical or conventional
PKCs that are calcium dependent and DAG sensitive namely
PKC-α, βI, βII, and γ; novel PKCs (δ, η, θ, µ, ε, ξ ) activated
by DAG but not calcium; and atypical PKCs (µ, ζ, υ, ι)
that are calcium independent and DAG insensitive (Newton,
1995). Each isotype triggers a different downstream signaling
pathway that can determine the ultimate outcome of an
infection. Therefore, there is a need to decipher the role of
PKC during CSOM in order to understand the pathogenesis
of the disease. In our study, we observed that PKC activation
in HMEECs in response to P. aeruginosa is abrogated in
the presence of calcium chelator, EGTA. This suggests that
P. aeruginosa activates the calcium dependent classical isoform
of PKC, most probably PKC-α. In agreement with this data,
expression of DN PKC-α significantly prevented the invasion of
HMEECs by otopathogenic P. aeruginosa and subsequent PKC
activation. Western blotting demonstrated that otopathogenic
P. aeruginosa specifically activates PKC-α but not the other
isotypes. Interestingly, PKC-α activation has been correlated with
increased cytokine production including TNF-α and IL-1β (Redig
and Platanias, 2007). Therefore, it is possible that activation of
PKC-α lead to exaggerated production of cytokines that is an
important hallmark of CSOM. High levels of cytokines leads to
tissue damage that further exacerbates the infection and worsens
the complications associated with CSOM.
Outer membrane proteins (OMPs) play an important role
in the interaction of pathogens with host cells (Galdiero et al.,
2012; Confer and Ayalew, 2013). In this study, we observed that
ability of otopathogenic P. aeruginosa to phosphorylate PKC-α
depends on OprF expression. OprF is one of the most abundant
OMPs/porin of P. aeruginosa (Sugawara et al., 2012). It has been
demonstrated that OprF controls the production of the quorum-
sensing-dependent virulence factors pyocyanin, elastase, lectin
PA-1L, and exotoxin A as well as Type III secretion system
associated enzymes, ExoS and ExoT, in non-otopathogenic
strains of P. aeruginosa (Fito-Boncompte et al., 2011). However,
our previous studies have demonstrated that OprF plays a
direct role in interaction of otopathogenic P. aeruginosa with
HMEECs (Mittal et al., 2014). The pretreatment of HMEECs
with exogenous OprF or pretreatment of WT P. aeruginosa
with anti-OprF mAb significantly reduced bacterial cell invasion.
On par with these findings, in this study also, we observed
that pretreatment of WT bacteria with OprF antibody abrogates
P. aeruginosa induced PKC-α activation in HMEECs. These
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results suggest that OprF plays a unique role in otopathogenic
P. aeruginosa and is directly involved in bacterial interaction with
HMEECs.
The migration of activated PKC to the cell plasma membrane
is essential to initiate the subsequent downstream signaling. In
most cell types, PKCs are present in a primed, yet inactive,
conformation in the cytosol, which are translocated to the
membrane upon activation. PKC attains its active conformation
when DAG recruits the inactive PKC to the membrane in a
calcium-dependent manner, where membrane binding provides
sufficient energy to disengage the pseudosubstrate, thus exposing
the substrate binding site. We observed that activated PKC in
response to P. aeruginosa migrates to the cell membrane. It is
possible that translocation of phosphorylated PKC-α to the cell
membrane facilitates the entry of P. aeruginosa inside HMEECs.
A significant decrease in invasion of HMEECs by P. aeruginosa
in the presence of PKC inhibitory peptide, which prevents the
translocation of PKC to the membrane, further demonstrates
the requirement of membrane-associated active PKC for the
successful bacterial cell invasion. These results are consistent
with the findings of other studies where activated PKC has been
shown to translocate to the plasma membrane. The adhesion of
Leishmania donovani to macrophages has been shown to produce
rapid and transient redistribution of PKC from the cytosol to
the plasma membrane (Bhunia et al., 1996). Enteropathogenic
E. coli has also been shown to activate PKC in HeLa and T84
cells which then migrate to the plasma membrane (Crane and Oh,
1997).
Cytoskeletal rearrangements play an important role in entry
and invasion of host cells by pathogens (Truong et al., 2014).
In our earlier study, we showed that P. aeruginosa induces
actin condensation during invasion of HMEECs. Here, we
observed that P. aeruginosa utilizes PKC pathway to cause
these cytoskeletal rearrangements. Confocal microscopy revealed
that activated PKC-α colocalizes with the actin beneath the
bacterial binding sites. In agreement with this findings, we
observed the translocation of MARCKS from membrane to
cytosol in P. aeruginosa infected HMEECs. MARCKs is a
major PKC substrate that is associated with the plasma
membrane and promotes cross linking of F-actin filaments in
the dephosphorylated state (Blackshear, 1993). Phosphorylation
of MARCKS by PKC facilitate its translocation from the
plasma membrane to the cytosol leading to actin polymerization
(Aderem, 1995). Thus, the translocation of MARCKs from
membrane to cytosol leads to actin cytoskeletal rearrangement
that facilitates the entry of P. aeruginosa into HMEECs.
In summary, our study provides novel insights into the
pathogenesis of CSOM and decipher the role of PKC signaling
pathway in the ability of P. aeruginosa to cause chronic ear
infection. A comprehensive understanding of the role of PKC-
α during CSOM employing animal models will pave the way
to design effective treatment modalities against the disease and
prevent consequent hearing loss as well as life-threatening CNS
disorders.
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